Abbott Laboratories ( ABT ):

* ABBOTT TO ACQUIRE EXACT SCIENCES, A LEADER IN LARGE AND

FAST-GROWING CANCER SCREENING AND PRECISION ONCOLOGY DIAGNOSTICS

SEGMENTS

* ABBOTT - EXACT SCIENCES SHAREHOLDERS TO RECEIVE $105 PER

SHARE

* ABBOTT: PROPOSED DEAL FOR TOTAL EQUITY VALUE OF

APPROXIMATELY

$21 BILLION.

* ABBOTT: ACQUISITION WILL BE IMMEDIATELY ACCRETIVE TO

ABBOTT'S

REVENUE GROWTH AND GROSS MARGIN

* ABBOTT: PROPOSED DEAL FOR TOTAL EQUITY VALUE OF

APPROXIMATELY

$21 BILLION

* ABBOTT - EXACT SCIENCES TO BECOME ABBOTT SUBSIDIARY

* ABBOTT: PROPOSED DEAL FOR ESTIMATED ENTERPRISE VALUE OF

$23

BILLION

* ABBOTT - FINANCING CONTEMPLATES ABSORPTION OF EXACT

SCIENCES'

ESTIMATED $1.8 BILLION OF NET DEBT

Source text:

Further company coverage: